Ganguli Malika P, Dimov Vesselin
Internal Medicine, Ross University School of Medicine, Bridgetown, BRB.
Allergy and Immunology, Cleveland Clinic Hospital of Florida, Weston, USA.
Cureus. 2023 Jul 22;15(7):e42287. doi: 10.7759/cureus.42287. eCollection 2023 Jul.
Chronic urticaria (CU) is a hive-like rash lasting over six weeks. Common associations include low vitamin D, thyroid autoantibodies, and (. ) infection, among others. Progesterone has been documented to trigger CU, by endogenous or exogenous progesterone. The use of intrauterine devices (IUDs) has been a popular source of birth control, with many containing progesterone. Although rarely reported, some patients have been seen to have an urticarial reaction after implantation of an IUD. Here, we present a case of a patient with progesterone-induced chronic urticaria, likely triggered by implantation of a 13.5 mg intrauterine device implant (Skyla®, Bayer, Whippany, NJ, USA). To the best of our knowledge, this is the first case to report the association between Skyla® and chronic urticaria.
慢性荨麻疹(CU)是一种持续六周以上的蜂巢状皮疹。常见的相关因素包括维生素D水平低、甲状腺自身抗体以及(.)感染等。已有文献记载,内源性或外源性孕酮可引发慢性荨麻疹。宫内节育器(IUD)一直是一种常用的避孕方式,许多宫内节育器含有孕酮。虽然报道较少,但已有一些患者在植入宫内节育器后出现荨麻疹反应。在此,我们报告一例由孕酮引起的慢性荨麻疹患者,可能是由植入一枚13.5毫克的宫内节育器(Skyla®,拜耳公司,美国新泽西州惠普尼)引发的。据我们所知,这是首例报道Skyla®与慢性荨麻疹之间关联的病例。